Last checked at 
(Alliance News) - PureTech Health PLC is exploring a listing of American depositary shares on the Nasdaq exchange in New York, it said Thursday, which would be backed up by an offering of new ordinary shares.
PureTech, a biopharmaceutical company which works on diseases in the brain, immune system, and gut, said the terms of the US listing have not been agreed, nor has the timing.
The US listing would not affect its current London listing, PureTech also said, and an update will come "if and when appropriate".
On Wednesday last week, PureTech investee Karuna Therapeutics Inc raised over USD100 million in an initial public offering on the Nasdaq. PureTech owns 32% of Karuna following the IPO.
PureTech shares were 0.6% lower on Thursday at a price of 230.51 pence each.
